|
Name |
4-Hydroxyisobenzofuran-1(3H)-one
|
Molecular Formula | C8H6O3 | |
IUPAC Name* |
4-hydroxy-3H-2-benzofuran-1-one
|
|
SMILES |
C1C2=C(C=CC=C2O)C(=O)O1
|
|
InChI |
InChI=1S/C8H6O3/c9-7-3-1-2-5-6(7)4-11-8(5)10/h1-3,9H,4H2
|
|
InChIKey |
ZSCIMKFWMUXNBS-UHFFFAOYSA-N
|
|
Synonyms |
4-Hydroxyisobenzofuran-1(3H)-one; 13161-32-5; 4-hydroxyphthalide; 4-hydroxy-3H-2-benzofuran-1-one; MFCD15143974; 4-hydroxy-1,3-dihydro-2-benzofuran-1-one; 4-hydroxy-2-benzofuran-1(3H)-one; SCHEMBL78594; DTXSID60506053; CHEBI:178339; 4-hydroxy-3H-2-benzouran-1-one; 4-hydroxy-3H-isobenzofuran-1-one; ZINC14505663; 4-Hydroxyisobenzo[b]furan-1(3H)-one; AKOS005166872; 4-Hydroxy-1(3H)-isobenzofuranone, 9CI; SY274862; WS-01368; CS-0324557
|
|
CAS | 13161-32-5 | |
PubChem CID | 12662077 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 150.13 | ALogp: | 1.0 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 11 | QED Weighted: | 0.57 |
Caco-2 Permeability: | -4.581 | MDCK Permeability: | 0.00003000 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.208 |
Blood-Brain-Barrier Penetration (BBB): | 0.726 | Plasma Protein Binding (PPB): | 77.15% |
Volume Distribution (VD): | 0.845 | Fu: | 23.86% |
CYP1A2-inhibitor: | 0.928 | CYP1A2-substrate: | 0.394 |
CYP2C19-inhibitor: | 0.403 | CYP2C19-substrate: | 0.137 |
CYP2C9-inhibitor: | 0.18 | CYP2C9-substrate: | 0.806 |
CYP2D6-inhibitor: | 0.377 | CYP2D6-substrate: | 0.607 |
CYP3A4-inhibitor: | 0.042 | CYP3A4-substrate: | 0.171 |
Clearance (CL): | 15.063 | Half-life (T1/2): | 0.902 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.103 |
Drug-inuced Liver Injury (DILI): | 0.363 | AMES Toxicity: | 0.739 |
Rat Oral Acute Toxicity: | 0.167 | Maximum Recommended Daily Dose: | 0.011 |
Skin Sensitization: | 0.385 | Carcinogencity: | 0.77 |
Eye Corrosion: | 0.225 | Eye Irritation: | 0.97 |
Respiratory Toxicity: | 0.071 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002236 | 0.512 | D07HBX | 0.289 | ||||
ENC006137 | 0.511 | D03GET | 0.264 | ||||
ENC000584 | 0.426 | D0Q5NX | 0.254 | ||||
ENC000856 | 0.426 | D00IUG | 0.254 | ||||
ENC002432 | 0.426 | D0C4YC | 0.250 | ||||
ENC005720 | 0.426 | D01WJL | 0.250 | ||||
ENC002082 | 0.426 | D0E9CD | 0.245 | ||||
ENC006108 | 0.408 | D0S2BT | 0.245 | ||||
ENC003193 | 0.404 | D05VLS | 0.240 | ||||
ENC005856 | 0.396 | D05VGL | 0.240 |